Background illustration for clinical trials search

Paid Clinical Trials Aurora

Discover 1,604 paid clinical trials in Aurora, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: Aurora CO, Phoenix AZ, Minneapolis MN, Calgary,
Sponsor: AbbVie

Sex: All

Age: 2 - 17

Code: NCT05995353

Phase 3, Recruiting

Pediatric Medication Therapy Management Trial

for
Child, Only, Disabilities Multiple, Medication Interaction,
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 2 - 18

Code: NCT05761847

Recruiting

Puberty, Testosterone, and Brain Development

for
Gender Identity, Gender Dysphoria in Adolescents and Adults,
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 12 - 20

Code: NCT06670053

Recruiting

Treatment of Neonatal Encephalopathy With Oral Sildenafil Suspension to Repair Brain Injury Secondary to Birth Asphyxia

for
Neonatal Encephalopathy
Location: Denver CO, Montreal
Sponsor: Pia Wintermark

Sex: All

Age: 0

Code: NCT06098833

Phase 2, Recruiting

COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

for
Complex Congenital Heart Defect, Dysfunctional RVOT Conduit,
Location: Aurora CO, Murray UT, Dallas TX, Rochester MN,
Sponsor: Edwards Lifesciences

Sex: All

Age: 0+

Code: NCT02744677

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

for
Neurofibromatosis Type 1
Location: Aurora CO, Dallas TX, St Louis MO, Los Angeles CA,
Sponsor: Healx Limited

Sex: All

Age: 12+

Code: NCT06541847

Phase 2, Recruiting

MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

for
Adamantinous Craniopharyngioma,
Location: Aurora CO, Cincinnati OH, Vancouver, Columbus OH,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 1 - 39

Code: NCT05286788

Phase 2, Recruiting

The Pediatric Anesthesia Quality Improvement Project

for
Surgery, Anesthesia, Children
Location: Aurora CO, Omaha NE, Phoenix AZ, Fort Worth TX,
Sponsor: The Society for Pediatric Anesthesia

Sex: All

Age: 0 - 21

Code: NCT00674388

Recruiting

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

for
Low Grade Astrocytoma, Low Grade Glioma,
Location: Aurora CO, Salt Lake City UT, Lubbock TX, Omaha NE,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 2 - 21

Code: NCT04166409

Phase 3, Recruiting

Post-operative Cesarean Trial of Pain Control

for
Post-operative Pain, Cesarean Section
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: Female

Age: 18 - 50

Code: NCT05131178

Recruiting

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

for
Heart Failure, Left Ventricular Systolic Dysfunction
Location: Aurora CO, Dallas TX, St Louis MO, San Bernardino CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT05714085

Phase 2, Phase 3, Recruiting

Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)

for
Obstructive Sleep Apnea, Down Syndrome
Location: Aurora CO, Dallas TX, Houston TX, Portland OR,
Sponsor: Oregon Health and Science University

Sex: All

Age: 2 - 17

Code: NCT05508971

Recruiting

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Aurora CO, Denver CO, Albuquerque NM, Salt Lake City UT,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT03959085

Phase 3, Recruiting

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

for
Embryonal Rhabdomyosarcoma,
Location: Aurora CO, Denver CO, Albuquerque NM, Salt Lake City UT,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT05304585

Phase 3, Recruiting

A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects

for
Neuroblastoma, Neuroectodermal Tumors, Neoplasms
Location: Aurora CO, Fort Worth TX, Dallas TX, Minneapolis MN,
Sponsor: Jubilant DraxImage Inc.

Sex: All

Age: 1+

Code: NCT03561259

Phase 2, Recruiting

Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children

for
Survivors of Childhood Cancer, Bladder Dysfunction
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 5 - 13

Code: NCT04993859

Recruiting

Decision Aid for Parents of Infants With UPJO

for
Ureteropelvic Junction Obstruction,
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 18 - 70+

Code: NCT05900375

Recruiting

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

for
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor,
Location: Aurora CO, Denver CO, Albuquerque NM, Salt Lake City UT,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT04322318

Phase 2, Recruiting

Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE

for
Eosinophilic Esophagitis
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 12 - 25

Code: NCT06705387

Phase 2, Recruiting

Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation

for
Infusion Reactions
Location: Aurora CO, Denver CO, Omaha NE, Oklahoma City OK,
Sponsor: New York Blood Center

Sex: All

Age: 0+

Code: NCT01656603

Phase 2, Recruiting